Navigation Links
Jubilant HollisterStier Allergy Launches 'Allergy Industry Insights' Educational Webinar Series
Date:8/31/2011

SPOKANE, Wash., Aug. 31, 2011 /PRNewswire/ -- HollisterStier Allergy, a division of Jubilant HollisterStier, is expanding their educational offerings for customers with the launch of Allergy Industry Insights, a series of free webinars for the allergist community. The webinars will serve as educational tools allergists can use to stay on top of developing trends and more effectively manage their practices.

The webinars will focus on relevant industry topics such as skin testing, reimbursement, and electronic medical records. Larry Garner, HollisterStier Allergy's National Allergy Consultant and well-known lecturer on allergy immunotherapy and dosing, will be hosting the webinars.

"These webinars will allow us the opportunity to educate and interact with a broader range of the allergy community," said Garner. "We are working to assist allergists in improving patients' lives and enhancing their practices by educating them on relevant industry topics."

The webinar series joins the Company's extensive collection of no-cost educational offerings for healthcare professionals, such as the Bee Aware Program launched recently by HollisterStier Allergy to educate emergency department personnel about stinging insect allergies and treatments.

The first webinar in the series will focus on Skin Testing and Diagnostic Guidelines and will be held August 31st.  Subsequent webinars will be held quarterly. Allergists will be able to register for the webinars and access previously recorded installments online, through the HollisterStier Allergy website.

About Jubilant HollisterStier's Allergy Division

Jubilant HollisterStier's Allergy Division is a leading manufacturer of high-quality allergy products for the global market. The organization provides a complete line of products for the testing and treatment of allergies. Its product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  Jubilant HollisterStier, located in Spokane, Washington,  is a subsidiary of  Jubilant Life Sciences Ltd., an integrated pharma and Life Sciences player, headquartered in India.  Jubilant HollisterStier is engaged in offering contract manufacturing services for sterile and non sterile products through its contract manufacturing & services division as well as providing Allergy products through the Allergy Division.  

For more information visit www.HSallergy.com.  For more information on the Bee Aware Program visit www.BeeAwareAllergy.org.

About Jubilant Life Sciences

Jubilant Life Sciences Limited is an integrated Pharma and Life Sciences Company.  It is the largest Custom Research and Manufacturing Services (CRAMS) Company and a leading Drug Discovery & Development Solutions provider out of India. The Company provides Life Sciences products and services across the value chain.  With 10 world-class manufacturing facilities and a team of ~5700 multicultural people across the globe, the Company is committed to deliver value to its customers spread in over 70 countries. The Company is well recognized as a "Partner of Choice" by leading life sciences companies worldwide.

For more information visit www.jubl.com

INQUIRIES:
Alison Marlin
509.951.0165
amarlin@jhs.jubl.com


'/>"/>
SOURCE Jubilant HollisterStier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jubilant Enters Research Collaboration With AstraZeneca
2. Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture
3. Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
4. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
5. Study Says Allergy Shots Help Children, Reduce Health Care Costs
6. American Lung Association Study Finds No Evidence of Depression or Suicide Linked to Asthma and Allergy Drug Montelukast
7. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
8. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
9. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
10. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
11. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
Breaking Medicine Technology:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... an official 2017 partnership with The Jensie Gran Fondo of Marin. For the ... UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide ...
(Date:2/23/2017)... ... 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased to announce ... a longtime supporter of the event. , "We are pleased that KLS Martin is ... Havlik, 2017 ACPA President. "KLS Martin has a long track record of support of ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, ... symposium on “Doping in Sport: How the Culture Might Change,” in ... LLP. The symposium will be held at Pepperdine University in Malibu, California. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare ... for those in the fight against cancer, has produced a seminal study that ... HRA will release top-line findings in a webinar, Defining Compassionate Care Through the ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):